230 related articles for article (PubMed ID: 15693140)
1. Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions.
Neves AR; Ensina LF; Anselmo LB; Leite KR; Buzaid AC; Câmara-Lopes LH; Barbuto JA
Cancer Immunol Immunother; 2005 Jan; 54(1):61-6. PubMed ID: 15693140
[TBL] [Abstract][Full Text] [Related]
2. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells primed with HPV positive cervical tumor lysate are superior to unprimed DCs in migratory capacity and induce a potent Th1 response.
Ramanathan P; Dhandapani H; Jayakumar H; Ganeshrajah S; Thangarajan R
Hum Immunol; 2014 Dec; 75(12):1216-24. PubMed ID: 25315748
[TBL] [Abstract][Full Text] [Related]
4. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells.
Radvanyi LG; Banerjee A; Weir M; Messner H
Scand J Immunol; 1999 Nov; 50(5):499-509. PubMed ID: 10564553
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: could it be a general phenomenon?
Clavijo-Salomon MA; Ramos RN; Crippa A; Pizzo CR; Bergami-Santos PC; Barbuto JA
Cancer Immunol Immunother; 2015 Feb; 64(2):161-71. PubMed ID: 25314913
[TBL] [Abstract][Full Text] [Related]
6. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
[TBL] [Abstract][Full Text] [Related]
7. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
[TBL] [Abstract][Full Text] [Related]
8. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
9. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
[TBL] [Abstract][Full Text] [Related]
10. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
[TBL] [Abstract][Full Text] [Related]
11. [Study on induction of dendritic cells from myeloid leukemia cell lines and their antitumor immune function].
Luo YP; Li YG; Cai DC; Ren H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):229-35. PubMed ID: 12513792
[TBL] [Abstract][Full Text] [Related]
12. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Dec; 75(3):217-27. PubMed ID: 14611813
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
14. The lymphoid chemokine CCL21 enhances the cytotoxic T lymphocyte-inducing functions of dendritic cells.
Hong CY; Lee HJ; Kim HJ; Lee JJ
Scand J Immunol; 2014 Mar; 79(3):173-80. PubMed ID: 24383579
[TBL] [Abstract][Full Text] [Related]
15. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
[TBL] [Abstract][Full Text] [Related]
16. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.
Huang YM; Stoyanova N; Jin YP; Teleshova N; Hussien Y; Xiao BG; Fredrikson S; Link H
Clin Exp Immunol; 2001 May; 124(2):306-14. PubMed ID: 11422209
[TBL] [Abstract][Full Text] [Related]
17. Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12).
Merad M; Angevin E; Wolfers J; Flament C; Lorenzi I; Triebel F; Escudier B; Zitvogel L
J Immunother; 2000; 23(3):369-78. PubMed ID: 10838666
[TBL] [Abstract][Full Text] [Related]
18. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.
Tawab A; Fan Y; Read EJ; Kurlander RJ
Transfusion; 2009 Mar; 49(3):536-47. PubMed ID: 19243546
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic efficacy of dendritic cells pulsed by autologous tumor cell lysate in combination with CIK cells on advanced renal cell carcinoma].
Wang H; Feng F; Zhu M; Wang R; Wang X; Wu Y; Zhuang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):67-71. PubMed ID: 25575061
[TBL] [Abstract][Full Text] [Related]
20. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
